Nektar Therapeutics
NKTR
#4538
Rank
โ‚น227.28 B
Marketcap
โ‚น6,727
Share price
2.83%
Change (1 day)
659.32%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -โ‚น13.57 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚น55.23 Million. a decrease over its 2024 earnings that were of -โ‚น11.54 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น15.06 Billion30.44%
2024 -โ‚น11.54 Billion-56.85%
2023 -โ‚น26.75 Billion-24.31%
2022 -โ‚น35.34 Billion-30.25%
2021 -โ‚น50.66 Billion17.87%
2020 -โ‚น42.98 Billion0.88%
2019 -โ‚น42.61 Billion-164.46%
2018 โ‚น66.09 B-810.61%
2017 -โ‚น9.31 Billion-37.06%
2016 -โ‚น14.78 Billion89.22%
2015 -โ‚น7.81 Billion48.22%
2014 -โ‚น5.27 Billion-65.93%
2013 -โ‚น15.47 Billion-6.81%
2012 -โ‚น16.6 Billion28.95%
2011 -โ‚น12.88 Billion258.8%
2010 -โ‚น3.59 Billion-63.94%
2009 -โ‚น9.95 Billion-392.45%
2008 โ‚น3.40 B-211.74%
2007 -โ‚น3.05 Billion-79.57%
2006 -โ‚น14.91 Billion-16.9%
2005 -โ‚น17.94 Billion81.53%
2004 -โ‚น9.88 Billion54.19%
2003 -โ‚น6.41 Billion-33.87%
2002 -โ‚น9.69 Billion-9.6%
2001 -โ‚น10.72 Billion73.39%
2000 -โ‚น6.19 Billion108.9%
1999 -โ‚น2.96 Billion39.48%
1998 -โ‚น2.13 Billion60.02%
1997 -โ‚น1.33 Billion18.05%
1996 -โ‚น1.13 Billion31.82%
1995 -โ‚น0.86 Billion57.14%
1994 -โ‚น0.55 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.515 T-16,808.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.025 T-6,911.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น879.71 B-5,944.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น49.18 Billion 226.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.273 T-8,558.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.419 T-9,531.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น97.77 M-100.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น22.96 B-252.56%๐Ÿ‡ฎ๐Ÿ‡ช Ireland